2020
DOI: 10.1016/j.regg.2019.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Colitis por citomegalovirus en paciente anciano inmunocompetente

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
1
0
0
Order By: Relevance
“…Among those, only six patients had no reported comorbidities, the remaining 14 had underlying conditions, with hypertension (40%); diabetes mellitus (30%) and chronic renal failure (15%) the most frequent. These findings are consistent with other studies such as the extensive literature review made by Karigane et al, where from all the 33 cases of CMV enteritis or colitis identified the mean age was 68 years old and the meta-analysis performed by Galiatsatos et al where from the all the 44 immunocompetent patients diagnosed with CMV colitis, only 10 had no associated co-morbid conditions [6,8,13,15,16]. Also, a recent study that compared CMV colitis in immunocompromised versus immunocompetent patients found that in the immunocompetent group the patients were older, had more comorbidities and were in worse general condition [17].…”
Section: Discussionsupporting
confidence: 90%
“…Among those, only six patients had no reported comorbidities, the remaining 14 had underlying conditions, with hypertension (40%); diabetes mellitus (30%) and chronic renal failure (15%) the most frequent. These findings are consistent with other studies such as the extensive literature review made by Karigane et al, where from all the 33 cases of CMV enteritis or colitis identified the mean age was 68 years old and the meta-analysis performed by Galiatsatos et al where from the all the 44 immunocompetent patients diagnosed with CMV colitis, only 10 had no associated co-morbid conditions [6,8,13,15,16]. Also, a recent study that compared CMV colitis in immunocompromised versus immunocompetent patients found that in the immunocompetent group the patients were older, had more comorbidities and were in worse general condition [17].…”
Section: Discussionsupporting
confidence: 90%